Back to Search Start Over

Factors associated with health‐related quality of life in heart failure in 23 000 patients from 40 countries: results of the G‐CHF research programme.

Authors :
Johansson, Isabelle
Balasubramanian, Kumar
Bangdiwala, Shrikant
Mielniczuk, Lisa
Hage, Camilla
Sharma, Sanjib Kumar
Branch, Kelley
Zhu, Jun
Kragholm, Kristian
Sliwa, Karen
Alla, Francois
Yonga, Gerald
Roy, Ambuj
Orlandini, Andres
Grinvalds, Alex
McCready, Tara
Pogosova, Nana
Störk, Stefan
McMurray, John J.V.
Conen, David
Source :
European Journal of Heart Failure; Sep2022, Vol. 24 Issue 9, p1478-1490, 13p, 1 Illustration, 1 Diagram, 5 Charts
Publication Year :
2022

Abstract

Aims: To examine clinical and social correlates of health‐related quality of life (HRQL) in patients with heart failure (HF) from high‐ (HIC), upper middle‐ (UMIC), lower middle‐ (LMIC) and low‐income (LIC) countries. Methods and results: Between 2017 and 2020, 23 292 patients with HF (32% inpatients, 61% men) from 40 countries were enrolled in the Global Congestive Heart Failure study. HRQL was recorded at baseline using the Kansas City Cardiomyopathy Questionnaire (KCCQ)‐12. In a cross‐sectional analysis, we compared age‐ and sex‐adjusted mean KCCQ‐12 summary scores (SS: 0–100, higher = better) between patients from different country income levels. We used multivariable linear regression examining correlations (estimated coefficients) of KCCQ‐12‐SS with sociodemographic, comorbidity, treatment and symptom covariates. The adjusted model (37 covariates) was informed by univariable findings, clinical importance and backward selection. Mean age was 63 years and 40% of patients were in New York Heart Association (NYHA) class III–IV. Average HRQL was 55 SD 27. It was 62.5 (95% confidence interval [CI] 62.0–63.1) in HIC, 56.8 (56.1–57.4) in UMIC, 48.6 (48.0–49.3) in LMIC, and 38.5 (37.3–39.7) in LICs (p < 0.0001). Strong correlates (estimated coefficient [95% CI]) of KCCQ‐12‐SS were NYHA class III versus class I/II (−12.1 [−12.8 to −11.4] and class IV versus class I/II (−16.5 [−17.7 to −15.3]), effort dyspnoea (−9.5 [−10.2 to −8.8]) and living in LIC versus HIC (−5.8 [−7.1 to −4.4]). Symptoms explained most of the KCCQ‐12‐SS variability (partial R2 = 0.32 of total adjusted R2 = 0.51), followed by sociodemographic factors (R2 = 0.12). Results were consistent in populations across income levels. Conclusion: The most important correlates of HRQL in HF patients relate to HF symptom severity, irrespective of country income level. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13889842
Volume :
24
Issue :
9
Database :
Complementary Index
Journal :
European Journal of Heart Failure
Publication Type :
Academic Journal
Accession number :
159612265
Full Text :
https://doi.org/10.1002/ejhf.2535